A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
The test manufacturer is the first to gain IVDR certification for a companion diagnostic under the new regulation.
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.